{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:50:16Z","timestamp":1757613016722,"version":"3.44.0"},"reference-count":17,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Pract Neurol"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:p>Peripheral neuropathy can be the first and only manifestation of necrotising primary immune-mediated vasculitis which, carries a high mortality. A clear idea of how to both recognise and treat peripheral nervous system vasculitis is important. We provide a practical approach to immediate and longer term treatment protocols.<\/jats:p>","DOI":"10.1136\/practneurol-2012-000464","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T20:48:52Z","timestamp":1368218932000},"page":"408-411","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["How to recognise and treat peripheral nervous system vasculitis"],"prefix":"10.1136","volume":"13","author":[{"given":"E A","family":"Marsh","sequence":"first","affiliation":[{"name":"Department of Neurology, Royal Gwent Hospital, Newport, UK"},{"name":"Department of Neurology, University Hospital of Wales, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L M","family":"Davies","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University Hospital of Wales, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J G","family":"Llewelyn","sequence":"additional","affiliation":[{"name":"Department of Neurology, Royal Gwent Hospital, Newport, UK"},{"name":"Department of Neurology, University Hospital of Wales, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,5,10]]},"reference":[{"key":"2025090409530636000_13.6.408.1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg029"},{"key":"2025090409530636000_13.6.408.2","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.1780330802","article-title":"The American College of Rheumatology 1990 criteria for the classification of vasculitis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2025090409530636000_13.6.408.3","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370206"},{"key":"2025090409530636000_13.6.408.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020286"},{"key":"2025090409530636000_13.6.408.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(96)80066-0"},{"key":"2025090409530636000_13.6.408.6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.V95842","article-title":"Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement","volume":"9","author":"Westman","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"2025090409530636000_13.6.408.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2006.00781.x"},{"key":"2025090409530636000_13.6.408.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)70249-0"},{"key":"2025090409530636000_13.6.408.9","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/110.4.843"},{"key":"2025090409530636000_13.6.408.10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1212\/WNL.55.5.636","article-title":"Superficial peroneal nerve\/ peroneous brevis muscle biopsy in vasculitic neuropathy","volume":"55","author":"Collins","year":"2000","journal-title":"Neurology"},{"key":"2025090409530636000_13.6.408.11","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-10-200905190-00004"},{"key":"2025090409530636000_13.6.408.12","first-page":"253","article-title":"Management of ANCA-associated vasculitis: current trends and future prospects","volume":"6","author":"Hamour","year":"2010","journal-title":"Ther Clin Risk Manag"},{"key":"2025090409530636000_13.6.408.13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel303"},{"key":"2025090409530636000_13.6.408.14","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/art.21142","article-title":"Randomisation trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody associated vasculitis","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2025090409530636000_13.6.408.15","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.088096"},{"key":"2025090409530636000_13.6.408.16","unstructured":"De Groot K Harper L Jayne DRW . EUVAS (European Vasculitis Study Group). CYCLOPS trial protocol. http:\/\/www.vasculitis.nl\/media\/documents\/cyclops.pdf"},{"key":"2025090409530636000_13.6.408.17","doi-asserted-by":"publisher","DOI":"10.1002\/art.10459"}],"container-title":["Practical Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/practneurol-2012-000464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T16:53:16Z","timestamp":1757004796000},"score":1,"resource":{"primary":{"URL":"https:\/\/pn.bmj.com\/lookup\/doi\/10.1136\/practneurol-2012-000464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,10]]},"references-count":17,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,11,11]]},"published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1136\/practneurol-2012-000464"],"URL":"https:\/\/doi.org\/10.1136\/practneurol-2012-000464","relation":{},"ISSN":["1474-7758","1474-7766"],"issn-type":[{"type":"print","value":"1474-7758"},{"type":"electronic","value":"1474-7766"}],"subject":[],"published":{"date-parts":[[2013,5,10]]}}}